Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia
Public ClinicalTrials.gov record NCT03015532. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-Blind, Saline Placebo- and Active-Controlled, Multicenter Study of HTX-011 Via Infiltration for Postoperative Analgesia in Subjects Undergoing Total Knee Arthroplasty
Study identification
- NCT ID
- NCT03015532
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Heron Therapeutics
- Industry
- Enrollment
- 285 participants
Conditions and interventions
Conditions
Interventions
- HTX-011 Drug
- Saline Placebo Drug
- Bupivicaine HCl Drug
- Ropivacaine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 12, 2017
- Primary completion
- Apr 19, 2018
- Completion
- May 15, 2018
- Last update posted
- Mar 1, 2026
2017 – 2018
United States locations
- U.S. sites
- 24
- U.S. states
- 7
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mobile | Alabama | 36608 | — |
| Not listed | Sheffield | Alabama | 35660 | — |
| Not listed | Phoenix | Arizona | 85015 | — |
| Not listed | Phoenix | Arizona | 85023 | — |
| Not listed | La Jolla | California | 92037 | — |
| Not listed | Riverside | California | 92503 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Miami | Florida | 33143 | — |
| Not listed | Miami | Florida | 33155 | — |
| Not listed | Tamarac | Florida | 33321 | — |
| Not listed | Las Vegas | Nevada | 89109 | — |
| Not listed | Columbus | Ohio | 43203 | — |
| Not listed | Columbus | Ohio | 43210 | — |
| Not listed | Dayton | Ohio | 45417 | — |
| Not listed | Bellaire | Texas | 77401 | — |
| Not listed | Houston | Texas | 77004 | — |
| Not listed | Houston | Texas | 77027 | — |
| Not listed | Houston | Texas | 77043 | — |
| Not listed | Plano | Texas | 75093 | — |
| Not listed | San Antonio | Texas | 78209 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | San Antonio | Texas | 78240 | — |
| Not listed | Webster | Texas | 77598 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03015532, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 1, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03015532 live on ClinicalTrials.gov.